Patents
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
11/2012
11/07/2012CN101380313B Famotidine high density type gastric retention osmotic pump controlled release preparation and preparation method thereof
11/07/2012CN101066260B Coenzyme Q10 emulsion and its freeze dried emulsion and their preparation process
11/07/2012CN101062024B Pronin medicinal composition and its preparing method
11/06/2012US8304426 Polymorphic form of Granisetron base, methods for obtaining it and formulation containing it
11/06/2012US8304414 Pyrazole compounds useful as protein kinase inhibitors
11/06/2012US8304409 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
11/06/2012US8304387 Therapeutic formulations of keratinocyte growth factor
11/06/2012US8303933 Multicomponent assemblies having enhanced binding properties for diagnosis and therapy
11/06/2012US8303932 Multicomponent assemblies having enhanced binding properties for diagnosis and therapy
11/06/2012CA2450257C Method of determining a chemotherapeutic regimen based on glutathione-s-transferase pi expression
11/06/2012CA2302743C Plant proanthocyanidin extract effective at inhibiting adherence of bacteria with p-type fimbriae to surfaces
11/01/2012WO2012148929A2 Disorders implicating pufa oxidation
11/01/2012WO2012148002A1 Method for modulating ion transporter
11/01/2012WO2012147916A1 Amide compound and pharmaceutical application therefor
11/01/2012WO2012147470A1 Peptide for inducing regeneration of tissue and use thereof
11/01/2012WO2012146890A1 Prebiotic agent
11/01/2012WO2012146881A1 Anti-inflammatory composition for the intestine including maltitol
11/01/2012WO2012146057A1 Curcuminoid injection solution and intravenous injection
11/01/2012WO2012146049A1 Traditional chinese medicine composition for treating oral cavity disease and the preparation technology and the quality testing method thereof
11/01/2012WO2012145899A1 Ester compound, preparation method and application thereof
11/01/2012WO2012145801A1 Nanoparticle
11/01/2012WO2012115479A3 Diaminopyrimidine derivatives and processes for the preparation thereof
11/01/2012WO2012092305A3 Nanonized iron compositions and methods of use thereof
11/01/2012US20120277316 Methods and compositions for treating and preventing parenteral nutrition associated liver disease
11/01/2012US20120277299 Method for modulating ion transporter
11/01/2012US20120277296 Selective CB2 Receptor Agonists for Use in the Prevention or Treatment of Alcoholic Liver Disease
11/01/2012US20120277292 ANTISENSE OLIGONUCLEOTIDES AGAINST cPLA2, COMPOSITIONS AND USES THEREOF
11/01/2012US20120277289 Activity generating delivery molecules
11/01/2012US20120277277 Methods of Treating a Hyperproliferative Disorder or Inhibiting Cell Growth in a Mammal
11/01/2012US20120277270 Method for Decreasing Symptoms of Alcohol Consumption
11/01/2012US20120277260 Use of methylnaltrexone and related compounds to treat constipation in chronic opioid users
11/01/2012US20120277259 Substituted benzofused derivatives and their use as vanilloid receptor ligands
11/01/2012US20120277240 Substituted aminotetrahydrothiopyrans and derivatives thereof as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes
11/01/2012US20120277238 Pharmaceutical composition containing fused hetero-ring derivative
11/01/2012US20120277228 Novel Azaheterocyclic Compounds
11/01/2012US20120277223 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
11/01/2012US20120277220 5 OXO-5,8-DIHYDROPYRIDO[2,3-d]PYRIMIDINE DERIVATIVES AS CAMKII KINASE INHIBITORS FOR TREATING CARDIOVASCULAR DISEASES
11/01/2012US20120277219 Novel pyridopyrazine derivatives, process of manufacturing and uses thereof
11/01/2012US20120277198 Polyhydroxylated bile acids for treatment of biliary disorders
11/01/2012US20120277186 Tricyclic Derivatives and Their Pharmaceutical Use and Compositions
11/01/2012US20120277182 Anoectochilus spp. polysaccharide extracts for stimulating growth of advantageous bacteria, stimulating release of granulocyte colony-stimulating factor, modulating t helper cell type i, and/or modulating t helper cell type ii and uses of the same
11/01/2012US20120277181 Lactulose for bowel evacuation
11/01/2012US20120277174 New macrolides and their use
11/01/2012US20120277153 Treating liver diseases
11/01/2012US20120277145 Compounds
11/01/2012US20120277142 Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same
11/01/2012US20120276220 Method of Treating Hepatitis
11/01/2012US20120276216 Therapeutic Water Treatment
11/01/2012US20120276215 Therapeutic Conditioned Media
11/01/2012US20120276212 Composition comprising plant and/or fish oils and non-oxidizable fatty acid entities
11/01/2012US20120276201 Compositions and method for treatment and prophylaxis of inflammatory bowel disease
11/01/2012US20120276192 Compositions and methods for sirna inhibition of icam-1
11/01/2012US20120276191 Treatment and Diagnosis of Macrophage Mediated Disease
11/01/2012US20120276143 Probiotic bifidobacterium strain
11/01/2012US20120276126 Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
11/01/2012US20120276113 Methods of treating and preventing colitis involving il-13 and nk-t cells
11/01/2012US20120276075 Synergic action of a prolyl protease and tripeptidyl proteases
11/01/2012US20120276070 Induced Pluripotent Stem Cells and Related Methods
11/01/2012US20120276066 Peptide Linked Cell Matrix Materials for Stem Cells and Methods of Using the Same
11/01/2012US20120276058 Methane reducing strains and methods of use
11/01/2012US20120276056 Method for Use of Biologic Agents Including Live or Dormant Forms of Bacteria and other organisms in Treating Infections, Inflammation and Other Diseases of Distal Small Intestine and Large Intestine
11/01/2012US20120276055 Composition containing bacterium capable of producing propionic acid bacterium, and use thereof
11/01/2012US20120276023 Biguanide preservation of precipitated calcium carbonate
11/01/2012US20120275996 IL-1 Binding Proteins
11/01/2012CA2834400A1 Fecal lactoferrin as a biomarker for determining disease severity and for monitoring infection in patients with clostridium difficile disease
11/01/2012CA2834343A1 Disorders implicating pufa oxidation
11/01/2012CA2834255A1 Peptide for inducing regeneration of tissue and use thereof
11/01/2012CA2833493A1 Amide compound and pharmaceutical application therefor
11/01/2012CA2833420A1 Oxymetazoline for the treatment of ano-rectal disorders
10/2012
10/31/2012EP2518072A1 Imidazopyridazine compounds
10/31/2012EP2518056A1 Seven-membered ring compound and pharmaceutical use therefor
10/31/2012EP2517718A2 Treatment of T-cell mediated diseases
10/31/2012EP2517715A1 Composition containing bacterium capable of producing propionic acid bacterium, and use thereof
10/31/2012EP2517711A1 Hyperlipemia-ameliorating agent, anemia-ameliorating composition, uric-acid-level-reducing composition, and foods and beverages
10/31/2012EP2516446A2 Substituted hexahydrochromeno[3,4-b]pyrroles with affinity for the serotonin receptor (5-ht) family
10/31/2012EP2516010A2 Lipids, lipid compositions, and methods of using them
10/31/2012EP2516007A2 Nutritional compositions and methods for optimizing dietary acid-base potential
10/31/2012EP2515937A1 Non-fermented compositions comprising a cereal based fraction and a probiotic and uses thereof
10/31/2012EP2515895A2 Oral care compositions and methods
10/31/2012EP2515851A1 Treatment for inflammatory bowel disease
10/31/2012CN102762572A Pyrazolo[5,1b]oxazole derivatives as crf-1 receptor antagonists
10/31/2012CN102762564A Ghrelin receptor agonist for treatment of dyscrasia
10/31/2012CN102762115A Formulations and methods for nutrient delivery
10/31/2012CN102757941A Hepatitis A virus strain HAV-ZL2012, vaccine prepared by using same and application thereof
10/31/2012CN102757880A Maca health-care wine and preparation method thereof
10/31/2012CN102757515A Method for extracting high-purity flavonoid and pectin from citrus peel
10/31/2012CN102757471A Novel active cytidine disodium triphosphate compound and pharmaceutical composition thereof
10/31/2012CN102757448A Macrocyclic kinase inhibitor compound, preparation method and application thereof as drug
10/31/2012CN102757441A Furano[3,2-g]chromene compounds and applications thereof
10/31/2012CN102757440A 1-(6,7-dihydro-5H-furan-[3,2-g]chromene-3-acetyl)-4-phenylpiperazine and applications thereof
10/31/2012CN102757420A Heterotactic aryl carboxylic acid compound, preparation method thereof, medicine composition comprising compound and application of compound
10/31/2012CN102755646A Medicament for treating TNF alpha related disorder
10/31/2012CN102755641A Application of chymotrypsin preparation in treating oral ulcer
10/31/2012CN102755635A Composition for improving gastrointestinal function and preparation method thereof
10/31/2012CN102755623A Medicine for treating acute gastroenteritis and preparation method thereof
10/31/2012CN102755620A Appetizing health care product used for hepatitis B patients
10/31/2012CN102755614A Multi-effect acupuncture point application ointment and preparation method
10/31/2012CN102755604A Health-care product for restraining hiccup
10/31/2012CN102755603A Medicament for treating recurrent canker sore due to insufficiency of yang and preparation method thereof
10/31/2012CN102755601A Traditional Chinese medicine for treating stomach illness and preparation method thereof